|
× |
 |
Trends in National Institutes of Health R01 Funding of Principal Investigators in Psychiatry by Gender PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy and Safety of Desvenlafaxine 50 mg/d for Prevention of Relapse in Major Depressive Disorder: A Randomized Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Migrant Crisis After Lockdown in India During the COVID-19 Pandemic: An Invisible Mental Health Tsunami PDF |
$40.00 |
|
$40.00 |
|
|
